Mr. Darren Alkins CEO at SPL – Scientific Protein Laboratories, speaks with IBI about their continued development in their science and technical expertise to meet …
In recent years, we have seen pharmaceutical company megadeals that saw Takeda acquiring Shire for a total value of $81.7 billion, Bristol-Myers Squibb’s acquisition of …
During the structural analysis of recombinant protein biopharmaceutical products, a significant challenge is posed by the issue of Post Translational Modifications (PTMs). This is a …
The drug discovery research industry is seeing a growing prevalence of chemically-modified, biologically-based therapeutic candidates. This trend creates urgent and novel challenges for data management …
Traditionally, vaccination has been used as a preventative strategy, aimed at curbing the impact of a wide range of infectious diseases. Over the past three …
According to the World Health Organization, cancer is responsible for 10 million deaths per year, and it is considered as the second leading cause of …
Investigators in the commercial and non-profit sectors have always faced pressure to accelerate their work while balancing the need for quality and the realities of …
First in human (FIH) studies are the key translational studies from preclinical to further clinical development processes. The goal of FIH studies is to investigate …
The rapidly growing field of cell and gene therapy is both exciting and confusing to many, including those who work in the medical community and …
Single-use technologies are becoming widely utilised in the biopharmaceutical industry for the benefit of offering a more flexible, cost-effective approach to cGMP manufacturing. Single-use technologies …
In recent years, nanomedicine has proven to be key in overcoming many of the challenges associated with poorly water-soluble drugs. Decreasing the size of drug …
Improved diagnosis is driving precision in treatment, accompanied by increasing regulation stringencies from the likes of the MHRA and FDA. This ensures processes, as well …
While medical research has found the path to lead us slowly but steadily out of the current pandemic, the strategies to prevent such pandemics from …
